Therefore, cIAP2 may be responsible for the induction of AKT signaling in TNBCs, whereas AKT activation in luminal-type breast cancer was mainly affected by the status of PIK3CA and other factors, independent of cIAP2 expression. The gene discussed is AKT1; the disease is breast cancer.